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1. INTRODUCTION 
 
 
 
 Amniotic fluid serves several functions, such as providing a medium for fetal 
growth and development, protecting the fetus from external trauma and maintaining 
intrauterine temperature. 
  
 Meconium stained amniotic fluid occurs in 10% of all pregnancies: in 5% of 
these (i.e. 1 : 200 of all pregnancies) the meconium is aspirated in to the lungs of the 
fetus. Meconium aspiration syndrome contributes to neonatal death in approximately 
10% of babies who aspirate (i.e. 1 : 2000 of all pregnancies). In the past, it was 
considered as a sign of fetal distress occurring only in response to hypoxia. But in 
most cases meconium in the amniotic fluid is benign and associated with term 
pregnancies. But there is a general agreement that the presence of meconium stained 
amniotic fluid is associated with increase in perinatal mortality and morbidity.  Many 
investigators does not believe that presence of meconium predict a poor out come 
unless it is accompanied by other signs of fetal distress.   
 
 How ever if aspirated by the fetus before or during delivery, meconium can 
obstruct the airways, interfere with gas transfer and cause respiratory difficulties. 
 
The increased perinatal mortality and morbidity in the presence of meconium 
stained amniotic fluid is mainly due to meconium aspiration syndrome occurring in 2 
– 10% of these neonates. 50 – 60% of infants whose amniotic fluid was meconium 
stained was reported to have meconium in their tracheas.  
 
Treatment strategies of deep suctioning of hypopharynx and nares during 
delivery and immediate tracheal suctioning after birth have been successful in 
reducing meconium aspiration syndrome. But despite aggressive airway cleaning, 
meconium aspiration is not always prevented, the causative factor being inutero 
aspiration.  
 
Amnioinfusion is a simple technique, which dilutes the amniotic fluid and has 
been studied as an additional tool to prevent meconium aspiration. It helps by physical 
dilution of the thick meconium and hence decreases the toxic effects of aspiration of 
thick meconium. It also increases the fluid around the fetus and thereby decreases 
cord compression and hence fetal hypoxia when present. 
 
 
  
2. AIM OF THE STUDY 
 
 To evaluate the effect of amnioinfusion in meconium stained amniotic fluid on 
• the incidence of intrapartum fetal heart rate abnormalities  
• the nature of labour and incidence of instrumental deliveries  
• the neonatal outcome  
• the incidence of Meconium aspiration syndrome 
 
 
3. REVIEW OF LITERATURE 
 
 Amnioinfusion was first described in 1954, but this technique did not gain 
popularity till the 1980s. It s use was first reported by Gabbe et al in 1976. He 
demonstrated in a rhesus monkey that removal of amniotic fluid produced variable 
deceleration and the replenishment of fluid with saline relieved the deceleration  
 
 In 1978 Meis et al evaluated patients with meconium passage in early and late 
labour and graded the presence of meconium as light or heavy. Heavy meconium 
passage in early labour was associated with increased fetal morbidity including 
abnormal fetal heart pattern, prolonged second stage of labour and increased operative 
interventions. It was also associated with higher incidence of neonatal morbidity and 
mortality. 
 
 Miyazaki and Taylor in 1983 infused saline through intrauterine pressure 
catheter to women in labour who had either variable deceleration or prolonged 
deceleration attributed to cord entrapment. They found this improved heart rate 
pattern in half the patients   
 
 Miyazaki and Nevarez in 1985 randomized 96 pregnancies and found 
multiparous  women in labour  with cord compression pattern who were treated with 
amnioinfusion less often required cesarean delivery for fetal distress.  
 
 Carson et al in 1976 described combined obstetric and pediatric approach to 
infants requiring tracheal suctioning at delivery  
  Wenstrom et al 1989 randomly compared 85 patients with thick meconium. 
The study group was infused with 1000 ml NS solution initially and every 6 hours 
until delivery. Control Patients received routine management. The incidence of low 1 
minute Apgar score, meconium below the vocal cords and operative delivery were 
significantly less in patients receiving amnioinfusion. They noted that amnioinfusion 
is a simple in expensive and safe technique that reduces the incidence of meconuim 
below vocal cords and improve the obstetric outcome in patients in labour with 
meconium. 
 
 Sadovsky et al 1989 demonstrated that 19 cases of labour treated with 
amnioinfusion for thick meconium had a better neonatal out come compared with 21 
cases treated routinely. The frequency of neonatal academia and positive pressure 
ventilation were significantly reduced in the infused group. 
 
 Charles J et al in 1992 studied 170 term and post term patients with thick 
meconium chosen to receive amnioinfusion or standard obstetric care with out 
amnioinfusion. The rate of fetal distress, caesarean section for fetal distress and rate 
of meconium aspiration syndrome were significantly reduced in amnioinfusion. 
 
 Eriksson and colleagues in 1994 found that amnioinfusion in pregnancy 
complicated by thick meconium stained amniotic fluid reduced the risk of meconium 
below the vocal cords and respiratory distress in the new born. 
 
 Lo et al in 1993 and Cialone et al 1994 reported a reduced frequency of 
academia, meconium aspiration syndrome and other neonatal complications in 
conjunction with amnioinfusion in the setting of thick meconium.  
 
 Hofmeyer et al 1998, for the collaborative randomized amnioinfusion for 
meconium project (CRAMP 1) South Africa did a multi center randomized controlled 
trial and found that amnioinfusion for meconium stained amniotic fluid reduces the 
incidence of meconium aspiration syndrome. 
 
 Mahomed et al 1998 (CRAMP 2) Zimbabwe found that meconium aspiration 
syndrome was significantly less frequent in amnioinfusion group and there was trend 
towards fewer perinatal deaths. In the study there was no difference in the rate of 
caesarean section.  
 
 John pierce et al 2000 did a meta analysis of 13 prospective clinical trials of 
Intrapartum amnioinfusion for meconium stained fluid. They reached a conclusion 
that amnioinfusion significantly reduced the frequency of meconium aspiration 
syndrome, meconium below the vocal cords and neonatal acidemia. The over all 
caesarean delivery rates were also significantly lower with out increased postpartum 
endometritis. 
 
 Vinita das et al did a prospective case control study in 2001 regarding the 
safety and efficacy of amnioinfusion during labour complicated by meconium stained 
liquor and found that amnioinfusion decreases the caesarean rate, incidence of 
meconium aspiration syndrome and perinatal mortality.  
 A.M. Rathor et al in 2002 did a randomized controlled trial in 200 women and 
found that caesarean section rate in amnioinfusion group was less than control group 
and amnioinfusion was associated with a significant decrease in the incidence of 
meconium at vocal cords, improvement in 1 minute Apgar score, respiratory distress 
and fewer admissions to NICU compared with that of controls. 
 
Conchrane database 2002 says amnioinfusion is associated with a reduction in 
heavy meconium staining of liquour, variable fetal heart decelerations and reduced 
caesarean section. Also associated with reduction in meconium aspiration syndrome, 
neonatal hypoxic ischaemic encephalopathy and neonatal ventilation or ICU 
admission. The database also showed a trend towards reduced perinatal mortality. It 
concluded that amnioinfusion is associated with improvement in perinatal outcome 
particularly as settings where facilities for perinatal surveillance are limited. 
 
G.Mukhopadhyay in 2002 did a study to evaluate the safety and efficacy of 
amnioinfusion and its effect on fetal outcome and found that amnioinfusion decreased 
the number of abdominal deliveries, decreased the incidence of meconium aspiration 
syndrome and decreased the admission to neonatal nursery. 
 
N.Talukdar in 2002 found in their study that amnioinfusion decreased the 
number of neonatal ICU admissions, birth asphyxia and meconium aspiration 
syndrome. 
 
Abhasingh and Dinesh Magu in 2005 say the use of amnioinfusion has been 
recognized the most in meconium stained amniotic fluid.  
 
Amnioinfusion is technically feasible in developing countries with limited 
intrapartum facilities.   
                                                                                                                                                                        
 
 
Fetal Heart Monitoring 
 
Since the introduction of fetal heart auscultation in the early 19th century by Evory 
Kennedy of Rotunda Hospital, Dublin, the estimation of the FHR has evolved 
considerably and become the mainstay of intrapartum fetal monitoring. Continuous 
electronic fetal heart rate monitoring (EFM) was introduced in the late 1960s and 
since then has attained wide acceptance in clinical obstetrics. During the interpretation 
of FHR recording, a systematic approach should be used to assess the following 
aspects. 
1. Baseline rate 
2. Baseline variability 
3. Presence of acceleration 
4. Presence of deceleration and their type and severity 
 
A normal FHR trace is one with a baseline rate between 110 and 160 bpm showing 
good variability (more than 5 bpm) with accelerations and no decelerations. In the 
presence of normal FHR trace there is only a 2% chance for the fetus to be acidotic 
(pH < 7.20) and a 1% chance for it to have a 5minute Apgar score < 7 (Beard et al 
1971; Steer et al 1989). A definitely ‘omnious’ or ‘pathological’ FHR trace is one 
with a baseline tacchycardia ( > 150 beats/min) with absent variability and repetitive 
late or variable decelerations. Other sinister patterns are prolonged severe braducardia 
( < 80 beats/min) for >10 minutes or a sinusoidal pattern without accelerations. 
 
Classification of Intrapartum CTG (FIGO 1987) 
1. Normal / Reassuring 
• Baseline heart rate 110-150 bpm 
• Baseline variability 5-25 bpm 
• Presence of accelerations of at least > 15 bpm lasting > 15 sec 
• Absence of decelerations 
 
2. Suspicious / equivocal 
• Absence of accelerations for > 40 minute 
• Baseline heart rate 150-170 bpm or 100-110 bpm 
• Absent baseline variability (< 5) for > 40 minutes, with normal base 
line and no decelerations 
• Variable decelerations < 60 bpm for < 60 sec 
• Transient prolonged bradycardia < 80 bpm for > 2 min or < 100 bpm 
for > 3 min 
 
3. Pathological / Ominous 
• Baseline FHR > 150 bpm with absent variability and /or respective late 
or variable decelerations 
• Absent baseline variability (<5) for > 90 min (1 1/2) hrs) 
• Complicated variable decelerations 
• Prolonged bradycardia (<80 bpm for > 10 min) 
• Sinusoidal pattern with no accelerations 
 
As subacute hypoxia develops during labour, the following FHR changes 
gradually develop: 1) absence of accelerations 2) gradual increase in baseline heart 
rate and 3) reduction in baseline variability. The presence of decelerations in the trace 
indicates the causative mechanism of hypoxia. While variable decelerations suggest 
cord compression, late decelerations indicate inadequate placental gas exchange. 
 
 
 
 
AMNIOINFUSION – GENERAL CONSIDERATIONS:  
 
Definition:   
  Amnioinfusion is a procedure in which a physiologic solution such as 
normal saline is infused into the amniotic cavity.  
 
Indications: 
Diagnostic:  
Antepartum 
¾ Sonographic evaluation of foetal anatomy in oligohydramnios 
¾ To determine the cause of oligohydramnios 
o Fetal anomalies 
o IUGR 
o PROM 
¾ Aspiration of amniofusate for chromosomal study 
 
Intrapartum 
¾ To Know the colour and type of fluid by the regurgitate solution, 
especially in cases where most of the liquor has been drained 
 
Prophylactic: 
Intrapartum 
¾ Oligohydramnios 
¾ PPROM 
¾ Prolonged rupture of membranes 
¾ Meconium stained amniotic fluid 
 
Therapeutic 
Antepartum 
¾ Restore amniotic fluid volume in oligohydramnios 
¾ Prolongation of pregnancy in PROM 
¾ Improvement in FHR variability 
¾ Improvement of odds of success after a failed version 
 
Intrapartum 
¾ Variable deceleration 
¾ Chorioamnionitis  
 
In addition to this, repeated trans abdominal amnioinfusion in patients with 
normally grown fetus but persistent oligohydramnios would prevent pulmonary 
hypoplasia and compression defects  
 
Intrapartum amnioinfusion for variable decelerations: 
 
 Many reports have documented relief of variable decelerations with trans 
vaginal amnioinfusion. Presumably more fluid is associated with less cord 
compression and thus relieves the variable decelerations, which are the result of cord 
compression. 
 
Intrapartum amnioinfusion for moderate or thick meconium stained amniotic fluid: 
 
 Many randomized studies have reported that amnioinfusion for moderate or 
thick meconium stained amniotic fluid is associated with a significant decrease in 
meconium aspiration. For amnioinfusion either RL or NS can be used, the type of 
solution used has not shown to affect the outcome. These solutions do not cause any 
electrolyte imbalance in the fetus.  
 
 Glanty and Letteney compared using warmed (37 c) versus room temperature 
infusion; they found no difference in the out comes. They also compared using 
infusion pump versus gravity and found both to be equally effective 
 
 
 
 
Routes of administration: 
Transabdominal (antepartum)           
               Following a prophylactic antibiotic, 20-22 G spinal needle connected to 
solution through IV tubing is placed in the amniotic cavity under USG guidance. The 
correct placement is conformed with the loss of resistance and free dispersal of 1-2ml 
of injected fluid, volume of infusate may vary from 200ml to 300ml depending upon 
its indication. 
 
Transcervical (intrapartum) 
             After spontaneous or artificial rupture of membranes intrauterine catheter 
(Nelaton catheter) / foleys’ catheter /nasogastric tubing is introduced through the 
dilated cervix beyond the head of the fetus. The catheter is connected to the solution 
which is infused by gravity or infusion pumps. 
 
Several protocols have been used for amnioinfusion  
Amount and type of fluid used in various studies 
Wenstrom and Parsons (1989) – 1000 ml NS over 20 – 40 min, repeated  
  every  6 hrs till delivery. 
Macri (1992) -  500 ml NS, then 250 ml increment to maintain AFI 10 
Cialone (1994) -    600 ml NS for 1st hr followed by 150 ml/hr till full dilatation 
The protocol used in this study was to infuse 1000 ml of NS as bolus dose 
over 40 minutes. Asper Wenstrom and Parsons study the dose was not repeated 
because no delivery was delayed for 6 hours in Meconium stained amniotic fluid. 
 
 
Complications due to amnioinfusion: 
Maternal 
Systemic: 
• Cardiopulmonary compromise 
• Amniotic fluid embolism 
Uterine and labour related: 
• PROM 
• Preterm labour 
• Iatrogenic Polyhydramnios 
• Cessarean section scar dehiscence 
• Amnionitis 
 
Fetal 
• Fetal bradycardia 
• Umbilical cord prolapse 
 
Maher et al reported two cases of amniotic fluid embolism in women when an 
amnioinfusion by infusion pump was ongoing. Several authors have reported the 
occurrence of excessive uterine contractions or unusually rapid labour progress 
associated with amnioinfusion. 
There is a hypothesis that excessive uterine contractions in some cases are 
related to extra amniotic placement of amnioinfusion catheter with simultaneous 
prostaglandin release.   
 
Rapid absorption of the infused fluid could account for the reported cases of 
pulmonary edema. Consensuses of reported data on infectious risk of amnioinfusion 
suggest that there is no increased risk of maternal and neonatal infection with 
amnioinfusion. 
 
Owen et al noted decrease in endometritis in women with amnioinfusion 
compared with those in control. 
 
 
Amnioinfusion in Meconium stained amniotic fluid : 
 
 Assuming that most of the meconium aspiration occurs at the first neonatal 
breath, Carson and associates (1976) reported that suction of the fetal nasopharynx 
immediately after delivery of the head but before the delivery of the body combined 
with tracheal intubation and suction was effective in reducing the incidence and 
severity of meconium. But Suresh and Sarkar (1994) noted that despite careful 
suctioning and lack of neonatal breathing before intubation, 75% still had meconium 
at trachea.   
 
 The current view is that Meconium aspiration occurs due to fetal breathing 
movements causing inhalation of amniotic fluid with meconium. The breathing which 
cause inhalation of amniotic fluid are of two types – Gasping and Deep breathing.  
 
 
 
Gasping: 
Gasping is a normal response to hypoxemia and can be induced 
experimentally by occluding the umbilical cord or by occluding the maternal aorta.  
 
Deep breathing: 
 
The fetus may also inhale Meconium by deep irregular breathing in utero, not 
initiated by hypoxia. These breathes become more frequent as gestation advances and 
comprise 10% of all fetal breathing movement. Fetal hypercapnoea and acidemia also 
increase these breathing movements. But these still occur in most of not all normal 
fetuses.   
 
Thick Meconium is viscid enough to obstruct neonatal airway and 
concentrated enough to cause significant chemical injury to the tissues. Starks (1980) 
found that thick Meconium was associated with a higher percentage of low Apgar 
scores. Mahomed and colleagues (1994) reported that patients with thin Meconium 
had outcomes indistinguishable from those with clear liquour. 
 
Amnioinfusion dilutes the Meconium and this reduces the toxic effects due to 
aspiration of thick Meconium. It also increases the volume of fluid around the fetus, 
thereby decreasing the possibility of fetal distress related to cord compression. 
 
PASSAGE OF MECONIUM IN UTERO     
 Meconium is found in the fetal gut from 10 weeks’ gestation but passage of 
Meconium is rare before 34 weeks. The incidence of Meconium passage during 
labour reaches 30% at 40 weeks gestation and 50% at 42 weeks. It  is an accumulation 
of debris that consists of desquamated cells from the alimentary tract and skin, lanugo 
hairs, fatty material from vernix caseosa, amniotic fluid and various intestinal 
secretions.  
 
 The quantity of Meconium in fetal gut is small during the first two trimesters, 
but increases rapidly during the third trimester. Because the internal and external anal 
sphincters are usually closed during fetal life, amniotic fluid ordinarily remains clear. 
Various stimuli are known to cause relaxation of anal sphincter tone and subsequent 
passage of Meconium in to amniotic fluid. 
 
It is suggested that any insult causing fetal hypoxia will cause fetal intestinal 
hyper peristalsis, relaxation of anal sphincter and thus passage of Meconium. 
However as Hon suggested parasympathetic stimulation from cord compression may 
stimulate Meconium passage without concomitant hypoxia.  
 
It is more likely that there is immaturity of the innervation of the fetal gut, 
with preterm fetuses having fewer myelinated axons and ganglion cells in the colon 
then term infants. Meconium passage in the preterm fetus can occur if it is infected 
with organisms which can cause a fetal enteritis eg:  Listeria monocytogenes, 
Ureaplasma urealyticum, rotaviruses.     
 
It is also possible that Meconium is passed as a result of spontaneous 
gastrointestinal motility that reflects physiological maturation of fetal gut. As the vast 
majority of fetuses have no acid base abnormality, the presence of Meconium itself is 
not a sensitive or specific indicator for the fetal compromise  
 
A number of studies have failed to show any consistent effects of Meconium 
stained amniotic fluid on Apgar scores, fetal scalp pH or incidents of fetal heart rate 
abnormalities (Abramnici et al 1974, Miller et al 1975, Baker et al 1992). Moreover 
one study found that although Meconium stained amniotic fluid correlated poorly 
with markers of acute intrauterine asphyxia (pH, lactate, Hypoxanthine 
concentration). It correlated well with blood erythropoietin concentration (marker of 
chronic asphyxia. Despite these theories, most physicians agree that Meconium 
stained amniotic fluid in connection with fetal heart rate abnormalities is a marker for 
fetal distress and is associated with increased perinatal morbidity and mortality  
            
 
 
 
 
 
 
Aetiology of meconium passage 
 
 
       Fetal hypoxio 
       ↓ 
    Cord compression   
     ↓   Fetal gut vasoconstriction 
              ↓ 
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     ↓   Sphincter  
 
   
   MECONIUM PASSAGE 
 
  
 
 
 
 
 
 
 
 
Meconium aspiration 
syndrome  
 Once Meconium has been passed, regardless of the stimulus, any episode of 
fetal gasping or respiratory attempts by the new born can cause aspiration of amniotic 
fluid containing Meconium into the fetal tracheo branchial tree. Meconium aspiration 
thus occurring can obstruct the airway; interfere with gas exchange and cause severe 
respiratory distress.  
 
 Meconium aspiration syndrome can occur in 10% of cases with Meconium 
stained amniotic fluid. It comprises a significant range of respiratory compromise. In 
its mildest form, the disease may present with neonatal tachypnoea associated with 
normal pH and lower Pco2, which resolves in 2 – 3 days. Clinically this mild 
respiratory morbidity was indistinguishable from transient tachypnoea of newborn. In 
the more severe form the syndrome can present as severe hypoxemia, acidosis, 
pneumothorax and respiratory failure a few hours after birth. Pulmonary arterial 
vasospasm may lead to right to left shunting through patent foramen ovale or 
ductusarteriosus. Hypoxia further stimulates pulmonary hypertension ultimately 
leading to convulsions, renal failure, DIC, and heart failure. 
  
        Clinically the infants with Meconium aspiration syndrome can have evidence of 
over inflation of lungs, with a barrel chest. Auscultation can reveal diffuse 
crepitations and rhonchi. The chest radiograph shows patchy areas of atelectasis and 
areas of over inflation. Pneumothorax and pneumomediastinum are common – 10 – 
20% (Peters and Pendleton 1989). Pleural effusion may be present in about 30%. But 
the severity of chest xray abnormalities may not correlate with the severity of clinical 
disease.  
 PATHOPHYSIOLOGY OF 
MECONIUM 
ASPIRATION  
 The pathophysiology of Meconium aspiration is extremely complex due to 
interplay of a large number of mechanisms. Perinatal asphyxia is a critical underlying 
factor in the pathogeneses of Meconium aspiration syndrome. The pulmonary 
abnormalities in Meconium aspiration syndrome are related primarily to acute airway 
obstruction, with obstructive emphysema due to ball valve effect.  
 
 Due to the direct irritation and toxicity of Meconium constituents, there is a 
marked alveolar and parenchymal inflammation and edema with leak of proteins into 
the airways. There is release of inflammatory mediators like cytokines. Meconium 
adversely affects the neutrophil function with inhibition of phagocytosis with 
increased risk of infection. Surfactant dysfunction may occur due to cytotoxic effect 
on type 2 pneumocytes and decreased level of surfactant protein A and B. There is 
increased airway resistance and reduced compliance of lungs.  
 
 Pulmonary vasoconstriction occurs due to injury of vascular bed of the lung. 
In these infants, vascular smooth muscle extends into the walls of normally non 
muscular intraacinar arterioles and reduces their luminal diameter which subsequently 
interferes with normal postnatal drop in pulmonary vascular resistance. In addition 
these infants may demonstrate plugs of platelets in their small vessels which reduce 
the cross sectional areas of pulmonary vascular bed. 
 
 
 
 
 
Pathophysiology of meconium aspiration 
Intrauterine hypoxia 
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↓ 
Meconium stained amniotic fluid 
↓ 
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Management of infant delivered through Meconium stained amniotic fluid: 
 In all cases of Meconium stained amniotic fluid, obstetrician should do the 
suction of oropharynx, mouth and nose as soon as the head of the baby is delivered.  
  
 In 1974, a prospective study by Gregory et al recommended laryngoscopy and 
tracheal intubation with suctioning for all the newborns born through thick particulate 
Meconium. In 1976, Carson et al reported a decrease in Meconium aspiration 
syndrome with suctioning of hypopharynx before the shoulders were delivered and 
before the first postnatal breathe. They recommended routine tracheal suctioning after 
as this was not necessary unless Meconium was visible at vocal cords or 
hypopharynx. Many studies (Wisewell et al; Hageman et al; Stickland et al) have 
shown beneficial effects of aggressive airway management. 
 
 In contrast AAP guidelines of perinatal care recommends endotracheal 
intubation and direct tracheal suctioning only if there is Meconium at the larynx on 
laryngoscopy and infant is depressed. 
 
 But the study by Wiswell showed that as many as 41 – 54% of infants in 
whom Meconium aspiration syndrome developed had Apgar score of 8 or grater. 
Thus a vigorous baby can still develop Meconium aspiration syndrome. 
 
The current management for any infant delivered with thick Meconuim Stained 
amniotic fluid: 
 
Place in radiant warmer, immediate intubation and suction of trachea via 
endotracheal tube with Meconium aspirator. 
   Repeat the suction till clear, assess for respiratory distress and empty the 
stomach contents - Meconium stained fluid detected 
       
Notify person skilled in neonatal resuscitation and capable of endotracheal  
intubation available    
  
Suction mouth and nasopharynx prior to delivery of the shoulders  
      
   Place infant on radiant warmer in Trendelenburg 
                                    
Thick or particulate Meconium  - immediately intubate and suction trachea through 
endotracheal tube with Meconium aspirator. Repeat until clear  
  
   Assess for respiratory distress and further management for Meconium aspiration 
syndrome. Empty the stomach contents.   
 
 
 
 
 
 
 
 
 
 
4. MATERIALS AND METHODS 
 
 
The study was conducted at Kilpauk medical college hospital, Chennai during 
the period of September 2004 to August 2005. For this prospective randomized 
controlled clinical study, 200 women in labour at term with moderate or thick 
Meconium stained amniotic fluid were included.  
 
 Inclusion criteria  
 Term pregnancies – Gestational age between 37 and 41 weeks  
 Singleton pregnancies  
 Vertex presentation 
 Normal fetal heart rate and rhythm  
Intact membranes at the admittance of the study and having moderate or thick 
Meconium stained amniotic fluid on spontaneous rupture of membranes or 
after doing artificial rupture of membranes in labour ward. 
 
Exclusion criteria 
 Multiple pregnancies  
 Fetal malpresentations  
 Fetal congenital anomalies  
 Prelabour rupture of membranes  
 Polyhydramnios 
 Antepartum hemorrhage 
Medical disease complicating pregnancies – anemia, heart disease, diabetes 
mellitus, pregnancy induced hypertension  
    Thin Meconium stained liquour. 
 
  
 Each patient was carefully examined for the presence of any risk factors. Gestational 
age was confirmed by detailed menstrual history, clinical examination and previous 
scan report if present. 
 
 Abdominal examination was done and fetal presentation determined. Duration 
and frequency of uterine contractions were assessed. The fetal heart rate was 
auscultated with pinard fetoscope.  
 
 Vaginal examination was done to assess the stage of labour and to confirm the 
fetal presentation. The amniotic fluid was examined after spontaneous rupture of 
membranes on artificial rupture of membranes and graded as  
 
Grade i –thin Meconium: having uniform greenish staining and watery 
Grade ii – moderate Meconium: having thicker greenish staining but still 
watery   
Grade iii – thick Meconium: green with particulate matter having pea soup 
quality (thick tenacious opaque)    
 
These patients were categorized into amnioinfusion group and no 
amnioinfusion group in a 1:1 ratio. The first patient was given amnioinfusion whereas 
second patient was taken as control group (without amnioinfusion).    The procedure 
was explained to the patient and consent obtained.      
 
NST tracing was taken soon after the rupture of membranes. In the 
amnioinfusion group the patient was asked to lie in dorsal position and Foleys 
catheter was introduced transcervically  under aseptic precautions such that its tip lies 
just above the baby’s head. Normal saline at room temperature was infused through 
the catheter using intravenous tube. 
 
The amnioinfusion was given as 1000 ml of normal saline over 40 minutes. 
The control group did not receive any catheter placement. Both groups were managed 
in the labour ward routinely.      
 
In the amnioinfusion group the NST tracing was repeated after giving 
amnioinfusion. In control group the NST tracing was repeated after 1 hour. 
 
Uterine tone and frequency of contraction were monitored by abdominal 
palpation. Oxytocin drip was started if contractions were not effective. Fetal heart rate 
was auscultated every 15 minutes during the first stage of labour and every 5 minutes 
during the second stage of labour using pinard fetoscope. Fetal distress was defined as 
fetal bradycardia(<120 beats/min)or fetal tachycardia(>160 beats/minute). 
 
Progress of the labour was monitored and obstetric assistance was given 
whenever necessary. Forceps application and delivery by caesarean section were done 
for fetal heart rate abnormalities or failure to progress such as arrest disorders or 
protraction disorder as indicated. 
 
          During delivery as soon as baby’s head was delivered, the eyes were cleaned 
and suction was applied to the oropharynx, mouth and nose before the delivery of the 
shoulders by the obstetrician. Any mucus or Meconium was aspirated. Peadiatirician 
attended all the newborns immediately. After suctioning of oropharynx and 
nasopharynx, laryngoscopic visualization of the vocal cords was done by the 
paediatrician. The presence or absence of Meconium below the vocal cords were 
evaluated and documented. The staining of baby with Meconium and one minute, five 
minute Apgar were observed and recorded. If the baby had respiratory distress or five 
minute Apgar score less than 6, then baby was taken to NICU and treated accordingly.    
 
After delivery patients were observed in labour ward for two hours and then 
shifted to postnatal ward. Babies were followed prospectively till the day of discharge 
from the hospital              
  
 
5. RESULTS AND ANALYSIS OF THE STUDY: 
 
Table 1: Age 
Age (in years) Amnioinfusion Group Control Group 
< 20 31 22 
21 – 25 42 53 
26 – 30  22 16 
> 30 5 9 
 
P Value : 0.17 > 0.05 – not significant 
In this study the age of  the amnioinfusion group is matching with the control 
group. 
 
Table 2: Parity 
Parity Amnioinfusion Group Control Group 
Nulli para 67 58 
Para 1 24 31 
Para 2 8 10 
Para 3 1 1 
 
P Value  = 0.62 > 0.05 – not significant 
In this study parity of both the groups were matching. In both the groups 
nulliparas were predominant.
 Table 3: Socio economic status  
Socio economic status Amnioinfusion Group Control Group 
1 0 0 
2 0 0 
3 0 0 
4 42 40 
5 58 60 
P Value = 1 > 0.05 – not significant 
In this study socio economic status of amnioinfusion group matching with the 
control group. In both groups socio economic status 4&5 were predominant. 
 
 
 
Table 4: Gestational Age 
Gestational Age ( in weeks) Amnioinfusion Group Control Group 
37 – 39  79 72 
40 – 41 21 28 
P Value = 0.249 > 0.05 – not significant 
In this study both groups were matching in relation to their gestational age. 
Most of the patients were between 37 to 39 weeks. 
 
 
 Table 5: Phase of labour in inclusion 
Phase of labour on 
inclusion 
Amnioinfusion Group Control Group 
Active Phase 85 83 
Latent phase 15 17 
 
P Value = 0.847 > 0.05 – not significant 
In amnioinfusion group 85 patients were in the active phase of labour 
compared to 83 in the control group. In control group 17 patients were in the 
latent phase of labour compared to 15patients in amnioinfusion group. Both 
the groups were matching with the phase of labour in inclusion.  
 
 
Table 6 : Oxytocin augmentation 
Oxytocin augmentation Amnioinfusion Group Control Group 
Given 64 67 
Not Given 36 33 
 
P Value = 0.726 > 0.05 – not significant 
Oxytocin augmentation was required in 64 patients in amnioinfusion group 
and 67 patients in control group. Both the groups were matching with the 
oxytocin augmentation requirement.  
  
 
 
 
Table 7: Intrapartam FHR Abnormalities 
Fetal Heart Abnormalities 
Amnioinfusion Group 
(After giving Amnioinfusion)  
Control Group 
Present 24 38 
Not Present 76 62 
 
P Value    < 0.05 – significant 
 
There were more cases of fetal distress in the control group (38) compared with 
the amnioinfusion group (24). P Value is < 0.05. This shows that amnioinfusion 
causes a significant reduction in fetal heart rate abnormality during labour. 
  
Table 8: Types of FHR Abnormalities in Amnioinfusion Group 
Types of Fetal Heart Abnormalities  Before giving  
Amnioinfusion 
After giving 
Amnioinfusion 
Tachycardia 8 8 
Bradycardia 5 5 
Loss of beat to beat variability 7 7 
Variable deceleration 14 4 
Total 34 24 
 
 
 
Table 9: Types of FHR Abnormalities in Control Group 
Types of Fetal Heart Abnormalities  First NST Second NST (after 
1 hour) 
Tachycardia 7 7 
Bradycardia 10 10 
Loss of beat to beat variability 7 7 
Variable deceleration 14 14 
Total 38 38 
 
Amnioinfusion significantly reduces the incidence of variable deceleration 
In control group there is no change in both NST tracings 
  
Table 10: Mode of Delivery 
Mode of delivery Amnioinfusion Group Control Group 
L N 61 51 
Out let 2 6 
L M C 3 4 
Vacuum 0 1 
LSCS 34 38 
 
P Value =  0.1859 > 0.05 – not significant 
 
When mode of delivery is considered 61 in amnioinfusion group and 51 in 
control group delivered by labour natural. 2 patients in amnioinfusion group 
and six patients in control group had outlet forceps delivery. Low mid cavity 
forceps used in 3 patients belonging to the amnioinfusion group and 4 patients 
in the control group. Vacuum forceps was needed in 1 patient in control group 
and none in the amnioinfusion group. 34 patients in the amnioinfusion group 
and 38patients in the control group were delivered by LSCS. This shows that 
amnioinfusion is not influencing the mode of delivery. 
 
 Table 11: Incidence of Instrumental Delivery  
Deliveries Amnioinfusion Group Control Group 
Instrumental 39 49 
L N 61 51 
P Value =  < 0.05 –   significant 
This study 39 patients of amnioinfusion group and 49 patients of control group 
were needed instrumental delivery. Where as 61 patients in amnioinfusion 
group and 51 patients were delivered by labour natural. 
 
Table 12: Indication for instrumental deliveries 
Indication Instrumental 
Delivery 
Amnioinfusion Group Control Group 
LSCS 21 34 
Forceps 3 4 
Fetal Distress 
  
Total 24 38 
LSCS 13 4 
Forceps 2 6 
Others 
  
Total 15 10 
 
P Value =  < 0.05 –   significant 
 Fetal distress was the indication for instrumental delivery in 24 patients of 
amnioinfusion group and 38 patients in control group. Where as other causes were the 
indication for instrumental delivery in 15 patients of amnioinfusion group and 10 
patients in control group and one patient in control group delivered by vacuum. 
Amnioinfusion decreases the incidence of fetal distress. 
 Table 13 : One minute Apgar   
One Minute Apgar Amnioinfusion Group Control Group 
0 – 4  3 10 
5 – 7 76 89 
8 – 10 21 1 
 
P Value : - 0.00 < 0.05 – Significant 
One minute apgar less than 4 was seen in 3 infants in amnioinfusion group and 
10 infants in control group, 5 – 7 was seen in 76 infants in amnioinfusion 
group and 89 infants in control group. 8 – 10 apgar score was seen in 21 
infants in amnioinfusion group and one infant in control group. 
 
 
Table 14 : 5 minute Apgar   
5 minute Apgar Amnioinfusion Group Control Group 
0 – 4 0 3 
5 – 7 9 48 
8 – 10 91 49 
 
P Value : 0.00 < 0.05 - Significant 
Five minute apgar score more than 7 was seen in 91 infants in amnioinfusion 
group and 49 infants in control group. Both one minute and five minute apgar 
score were singnificantly raised in amnioinfusion group. 
 
 Table 15 : Baby weight    
Baby Weight ( in Kgs) Amnioinfusion Group Control Group 
2 – 2.5 29 28 
2.6 – 3 40 32 
> 3 31 40 
 
P Value : 0.35 > 0.05 – Not Significant 
 
In this study, birth weight of the babies of the amnioinfusion group matching 
with the control group. 
 
 
 
Table 16 : Grading of Meconium in Inclusion   
Meconium Grading Amnioinfusion Group Control Group 
Moderate 75 78 
Thick 25 22 
 
P Value : 0.18 > 0.05 - not Significant 
     
 
In this study,  Grading of the meconuim in inclusion of the amnioinfusion 
group matching with the control group. 
 Table 17 : Meconium below vocal cord   
Meconium below vocal 
cord 
Amnioinfusion Group Control Group 
Present 10 27 
Absent 90 73 
 
P Value : 0.0035 < 0.05 - Significant    
 
In this study the presence of meconuim below the vocal cord was significantly 
raised in control group. 
 
 
Table 18 : Incidence of Meconium aspiration syndrome   
Meconium aspiration 
syndrome 
Amnioinfusion Group Control Group 
  3  14  
 
P Value : 0.00 < 0.05 – Significant 
 
The incidence of meconium aspiration syndrome in amnioinfusion group 3 in 
number (presence of  meconium below the vocal cord were in 10 patients) 
where as 14 in number of control group.  (presence of  meconium below the 
vocal cord were in 27 patients). This is significant. 
 
 
 Table 19 : Admission in NICU   
Admission in NICU Amnioinfusion Group Control Group 
Admission  13 31 
No Admission 87 69 
 
P Value : 0.00 < 0.05 – Significant 
 
13 neonates of amnioinfusion group and 31 neonates of control group were 
needed admission in NICU. Amnioinfusion reduces the need of admission in 
NICU. 
 
Table 20 : Reasons for Neonatal admission   
Reason  Amnioinfusion Group Control Group 
Observation 7 13 
MAS 3 14 
Birth Asphyxia 3 4 
 
P Value : 0.00 < 0.05 – Significant 
 
7 neonates in the amnioinfusion group and 13 neonates in the control group 
were admitted for observation. 3 neonates of the amnioinfusion group and 4 of 
the control group were admitted for birth asphyxia, where as 14 neonates of 
the control group and 3 of the amnioinfusion group were admitted for 
Meconium Aspiration Syndrome. Meconium aspiration syndrome is the 
predominant cause for the NICU admission in the control group. 
 
 
 
Table 21 : Perinatal morbidity and mortality   
Perinatal Outcome Amnioinfusion Group Control Group 
Perinatal Morbidity 13 31 
Perinatal  Mortality 0/100 2/100 
 
P Value : 0.00 < 0.05 – Significant 
 
Perinatal morbidity and mortality were increase in the control group. 
Amnioinfusion decrease the perinatal morbidity and morality.  
 
 
 
Table 22 : Nature of delivery in Latent phase  
 
Nature of delivery  Amnioinfusion Group Control Group 
LSCS 10 12 
LMC 1 0 
LN 4 5 
Total 15 17 
 
P Value : >  0.05 – not Significant 
 
Nature of the delivery in the amnioinfusion group was matching with the 
control group. 
 
6. DISCUSSION 
 
 
In this prospective study, patients with moderate and thick Meconium stained 
amniotic fluid, 100 patients received amnioinfusion and 100 patients did not receive 
amnioinfusion. 
 
The amnioinfusion group and control group were matched with respective to age, 
parity and gestational age.  
 
More patients in both the groups were in the active phase of labour on inclusion than 
latent phase but this difference  was not significant.  
 
The number of patients receiving oxytocin for augmentation is not influenced by 
amnioinfusion (64% versus 67% - P value > 0.05) 
 
But in the study by Vsta et al, the amnioinfusion group had significantly higher 
incidence of oxytocin use than the control group ( 44% versus 23% - P value < 0.001). 
The study  of Cialone et al also showed the patient receiving amnioinfusion had 
greater oxytocin requirement in labour. 
 
In this study there is no significant difference between the two groups in the rupture 
of membrane to delivery interval (2.44 hrs versus 2.24 hrs). This is correlating with 
the study of Cialone et al in which the rupture of membrane to delivery interval was 
similar in both groups. Vsta et al showed longer interval in the amnioinfusion group. 
 
The incidence of fetal distress in this study was 24% in the amnioinfusion group and 
38% in the control group ( P < 0.05). This is statistically significant. This is in par 
with Wenstrom and Parson study which showed decrease in the incidence of fetal 
distress in  the amnioinfused patients. But in contrast study by Rogers et al showed a 
higher incidence of fetal distress in the amnioinfused group. (30.5% versus 19.7 %). 
Ericson et al also demonstrated that the incidence of fetal distress was not 
significantly different between the two groups, which is in contrast to this study.  
 
Taking into account on the phase of labour on inclusion most of the patients in latent 
phase of labour delivered by caesarean section while most of the patients in the active 
phase of labour on inclusion delivered vaginally. 
 
There was no significant difference between the two groups regarding the mode of 
delivery. Results of other study on the effect of intrapartum amnioinfusion on 
caesarean section rates are given in the table below(Table A). The last three studies 
mentioned in the table show a reduction in the caesarean section rates with the 
amnioinfusion while other studies do not show a significant difference. 
  
 
In this study the number of operative deliveries for fetal distress were significantly 
lower than that in control group ( 24% versus 38% - P Value < 0.05). This is similar 
to the result in the study by A.M. Rathore et al (12% versus 26%). Lo and Rogers, 
Hoodley et al and Marci et al also reported similar findings. Ericsen et al and Sponge 
et al reported no effect on caesarean section for fetal distress. Vsta et al reported a 
higher incidence of caesarean delivery in the amnioinfusion group (28% versus 17%)  
 
especially for fetal distress (16% versus 11%). The CRAMP 1 & 2 also showed no 
significant difference in the caesarean section rates for fetal distress between the two 
groups.  
 
 
In this study, the one minute Apgar score < 4 was 3% versus 10% (P value < 0.05).  
 
One minute Apgar score 5 – 7 was 76% versus 89% ( P value < 0.05) and  
 
One minute Apgar score 8 – 10 was 21% versus 1% (P value < 0.05).  
 
5 minute Apgar score  
 < 7 was 9% versus 48% - P value < 0.05  
 8 – 10 was 91% versus 49% - P value < 0.05 
 
Hence the fetal out come was good with the amnioinfusion group than the control 
group. A.M.Rathore et al reported similar findings in their study. The studies by 
Wenstrom and Passon, Marci et al, Keith and Rogers et al showed a significant 
decrease number of babies with low Apgar in the amnioinfusion group. 
 
In this study, the presence of meconium below the level of vocal cord is significantly 
reduced in the amnioinfusion group. ( 10% versus 27% - P value < 0.05). The 
incidence  in the other studies given in table B. All the studies show a reduction in the 
incidence of meconium below the level of vocal cord with amnioinfusion except that 
of Sponge et al and Vsta et al. 
 
The incidence of Meconium Aspiration Syndrome in this study 3 versus 14 ( P value 
< 0.05).  This shows that there is significant decrease in the incidence of meconium 
aspiration syndrome in the amnioinfusion group. Other studies showing similar results 
are give n in table C. All the studies show decrease in the incidence of meconium 
aspiration syndrome with amnioinfusion. 
 
In this study 13 neonates from the amnioinfusion group and 31 from the control group 
needed admission in the NICU. This shows that there is a significant decrease in the 
neonatal admissions in the amnioinfusion group (13% versus 31% - p value < 0.05). 
CRAMP 2 Zimbabwe arm showed similar results (12.8% versus 22.9%). The study 
by A.M.Rathore et al also showed decresed neonatal admissions in the amnioinfusion 
group (3% versus 11%). Studies by Erikssen et al, Cialone et al and CRAMP 1 South 
African arm also showed similar results. 
 
In this study, the perinatal mortality rate in the amnioinfusion group is 0% while in 
the control group is 2%. The difference is not significant statistically. In the CRAMP 
2 study conducted in Zimbabwe the perinatal mortality was 1.2% in amnioinfusion 
group versus 3.6%  in the control group. In the study by A.M.Rathore et al the 
perinatal moratality rate was 2% in the amnioinfusion group and 5% in the control 
group. G.Mukhopadhyaye showed a perinatal mortality rate of 2% in the 
amnioinfusion group and 11% in the control group. 
 
In this study, no adverse effects were noted in the fetus or mother due to 
amnioinfusion.  
 
 
 
 
 
 
 
Table A: Intrapartum amnioinfusion and LSCS rates 
 
 
 
Study Amnioinfusion Groups (%) Control Groups (%) 
Spong et al – 1994 8 / 43 (18.6) 9 / 50  (18) 
Galon et al – 1994 14 / 47 (29.8) 11 / 58 (19) 
Hofmeyr et al – 1998 70 / 167 (41.9) 68/ 159 (42.8) 
Mohamed et al – 1998 30 / 317 (9.5) 37 / 328 (11.3.) 
Moodley et al –1998 3 / 30 (10) 7 / 30 (23) 
Khosia et al - 1997 1 / 25 (4) 7/25 (28) 
A M Rathore et al – 2002 21 / 100 (21) 36 /100 (36) 
Present Study 34 / 100 (34) 38 / 100 (38) 
 
 
 
Table B: Intrapartum Amnioinfusion and presence of Meconium below the vocal 
cord 
 
 
Study Amnioinfusion Groups (%) Control Groups (%) 
Sadorsky et al 1989 0 / 19 (0.0) 6 / 21 (28.6) 
Macri et al 1992 4 / 85 (4.7) 33 / 85 (38.8) 
Sprg et al 1994 3 / 43 (7.0) 2 / 50 (4.0) 
Gialong et al 1994 2 / 47 (4.2) 34 / 58 ( 58.6) 
Ericson et al 1994 1 / 65 (1.5) 8 / 59 (13.6) 
USK et al 1995 28 / 97 (29.0) 31 / 112 (28.0) 
Hofmeyr et al 1998 6 / 158 (3.8) 12 / 164 (7.3) 
Khosh et al 1997 3 / 25 (12.0) 4/125 ( 16.0) 
A. M Rathore et al 2002 10 / 100 (10.0) 24 / 100 (24) 
Present Study 10 /100 (10.0) 29 / 100 (29.0) 
 
 
 
 
 
 
 
 
  
Table C: Intrapartum Amnioinfusion and Meconium Aspiration Syndrome 
 
Study 
Amnioinfusion Groups 
(%) 
Control Groups (%) 
Wenstrom et al 1989 0 / 36 (0.0) 3 / 44 (6.8) 
Macri et al 1992 0 / 85 (0. 0) 5 / 85 ( 5.9) 
Lo and Rogess et al 1993 1 / 60 (1.7) 3 / 52 (5.8) 
Cialna et al 1994 1 / 47(2.1) 6 / 58 (13.6) 
Ericson et al 1994 0 / 65 (0.0) 2 / 59 (3.4) 
USK et al 1995 19 / 497 (3.8) 20 / 440 (4.5) 
Mohamed et al 1998 10 / 323 (3.1) 42 / 329 (12.8) 
A. M Rathore et al 2002 0 / 100 (10.0) 1 / 100 (1.0) 
Present Study 3 / 100 (3.0) 14 / 100 (14.0) 
 
                                                          
7. SUMMARY 
 
In this prospective case controlled study, 200 patients with moderate or thick 
meconium strained amniotic fluid were selected from labour ward. Among them 100 
were given Amnioinfusion and grouped as amnioinfusion group. The other 100 were 
kept as control group with out giving amnioinfusion. 
 
In analyzing the intrapartom course and perinatal outcome, the following points were 
summed up: 
 
1. Majority of patients in amnioinfusion group and control group were in the age 
group of 19-30. Only 5% in amnioinfusion group and 9% in the control group 
were above 30 
2. The parity is also same in both the groups. Majority of the patients were 
nullipara - 67% in amnioinfusion group and 58% in control group. 
3. The gestation age for majority of the patients in the amnioinfusion group and 
control group were between 37 to 40 weeks. Only 21% of the amnioinfusion 
group and 28% in the control group had gestational age above 40 weeks. 
4. On inclusion majority of the patients were in the active phase of labour. 85% 
in amnioinfusion and 83% in the control group 
5. Augmentation with oxytocin was needed in 64% patients in the amnioinfusion 
and 67% in control group. 
 
 
 6. The mean duration of labour from rupture of membrane to delivery was 2.44 
hrs in the Amnioinfusion group and 2.24 hrs in control group. The difference 
is not significant and this shows that in this study there was no effect on the 
duration of labour by Amnioinfusion. 
 
7. The incidence of FHR abnormalities was significantly lower in the 
Amnioinfusion group, 24% versus 38% in the control group. 
 
8. Considering the mode of delivery, majority of the patients in both the groups 
delivered by L N 61% in Amnioinfusion group and 51% in control group. The 
incidence of instrumental vaginal delivery was 5% in amnioinfusion group and 
11% in control group. 
 
9. The number of patients who delivered by LSCS was 34% in Amnioinfusion 
and 38% in control group which is not significant. 
 
10. There was significant  decrease in the number of LSCS done for fetal distress 
in Amnioinfusion group, 21% versus 34% in control group. 
 
11.  Most of the patients who were included in the study in the latent phase of 
labour underwent LSCS. 
 
12. Discussing about the perinatal outcome, there was significant decrease in the 
number of babies with low Apgar score. 
 
13. The presence of meconium below the vocal cords was significantly reduced in 
the amnioinfusion group, 10% versus 27% in the control group. 
  
14. The incidence of meconium aspiration syndrome was also significantly 
reduced in amnioinfusion group, 3 versus 14 in control group. This shows that 
amnioinfusion is effective in reducing meconium below vocal cord and 
meconium aspiration syndrome. 
 
15. New born babies admitted in NICU was lower in amnioinfusion group than 
the control group (13% versus 31%). Hence there is significant decrease in the 
neonatal admission in the amnioinfusion group. 
 
16. Perinatal mortality in amnioinfusion group 0% where as in control 2%. 
 
17. There are no adverse maternal or fetal complications reported with 
amnioinfusion in this study. 
 
 8. CONCLUSION 
 
 
In this study it is found that the use of amnioinfusion has significantly reduced the 
number of intrapartum fetal heart rate abnormalities. 
 
Amnioinfusion has no effect on the mode of delivery in patients with meconium 
strained amniotic fluid in labour. The incidence of caesarean deliveries is not reduced 
but the number of caesarean section done for fetal distress has been decreased by the 
use of amnioinfusion. 
 
The study shows a drastic improvement in the perinatal outcome in the patients who 
received amnioinfusion. There was significant improvement in the one minute and 
five minute Apgar score, decrease in the incidence of meconium below the level of 
vocal cord and decrease in meconium aspiration syndrome. The number of babies 
admitted in NICU is also significantly reduced in the amnioinfusion group. 
 
To conclude, amnioinfusion is a safe, easy and effective procedure, which needs little 
expertise and can be done in labour ward even with limited facilities to improve 
neonatal outcome in meconium stained liquour. The use of such simple technique is 
very useful and effective in developing countries even with limited newborn care 
facilities. It is also very cost effective. 
9. PROFORMA 
 
Name :   Age :    I.P. No.:  DOA: 
          DOD: 
Gravida Para  LMP 
    EDD 
Booked / Unbooked 
Socio-economic status 
Gestational Age 
Duration of First Stage of Labour 
Duration of Second Stage of Labour 
Colour of Liquar when membrane ruptured – Meconuim Moderate 
        Thick 
 
Time Interval between rupture of membrane to delivery 
 
General Examination 
Nutrition Height 
Anemia Weight 
Pedal Edema 
Vital Signs -  P.R 
   B.P 
   Temp 
CVS : 
RS : 
P/A : 
P/V : 
Investigations  
Urine -  Alb    Blood Group and Rh type 
  Sugar 
  Deposits 
Hb 
 NST 
Baseline FHR 
Beat to beat Variability 
Acceleration 
Deceleration -  
Amnioinfusion  : Given / Not Given 
Repeat NST 
Baseline FHR 
Beat to beat Variability 
Acceleration 
Deceleration - 
Oxytocin Augmentation - Given / Not Given  
Mode of Delivery 
 Labour Natural 
 Forceps 
 LSCS   Indication 
Baby 
 TOD   Birth Weight   Sex 
 Apgar  1 Minute  5 Minute 
Resuscitation Method 
Condition of Baby - Admission    No Admission 
Meconium Below the vocal cord 
Meconium Aspiration Syndrome 
Other Neonatal Complication 
Neonatal mortality and cause 
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